79.95
-0.46 (-0.57%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | BridgeBio Pharma, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -3.5 |
| Price Volatility | -0.5 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | -0.5 |
| Average | 0.06 |
|
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 4.97% |
| % Held by Institutions | 98.14% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| APULI MARICEL | - | 79.86 | -4,714 | -376,460 |
| KUMAR NEIL | - | 82.26 | -81,217 | -6,636,027 |
| TRIMARCHI THOMAS | - | 79.86 | -22,781 | -1,819,291 |
| Aggregate Net Quantity | -108,712 | |||
| Aggregate Net Value ($) | -8,831,778 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 81.30 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| KUMAR NEIL | Officer | 19 Aug 2026 | Automatic sell (-) | 10,000 | 83.95 | 839,500 |
| KUMAR NEIL | Officer | 18 Aug 2026 | Automatic sell (-) | 34,980 | 82.98 | 2,902,640 |
| APULI MARICEL | Officer | 16 Aug 2026 | Disposed (-) | 4,714 | 79.86 | 376,460 |
| KUMAR NEIL | Officer | 16 Aug 2026 | Disposed (-) | 36,237 | 79.86 | 2,893,887 |
| KUMAR NEIL | Officer | 16 Aug 2026 | Option execute | 71,217 | - | - |
| TRIMARCHI THOMAS | Officer | 16 Aug 2026 | Disposed (-) | 22,781 | 79.86 | 1,819,291 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |